Susquehanna International Group’s Cellect Biotechnology Ltd. Warrants to Purchase ADRs APOPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-28,500
| Closed | -$5K | – | 13152 |
|
|
2020
Q4 | $5K | Buy |
28,500
+8,740
| +44% | +$1.47K | ﹤0.01% | 10933 |
|
|
2020
Q3 | $2K | Buy |
+19,760
| New | +$1.56K | ﹤0.01% | 10457 |
|
|
2020
Q2 | – | Sell |
-16,474
| Closed | -$1K | – | 11324 |
|
|
2020
Q1 | $1K | Sell |
16,474
-2,080
| -11% | -$157 | ﹤0.01% | 10140 |
|
|
2019
Q4 | $1K | Sell |
18,554
-2,396
| -11% | -$269 | ﹤0.01% | 9600 |
|
|
2019
Q3 | $0 | Buy |
20,950
+3,355
| +19% | +$345 | ﹤0.01% | 11106 |
|
|
2019
Q2 | $1K | Buy |
17,595
+194
| +1% | +$24 | ﹤0.01% | 10129 |
|
|
2019
Q1 | $2K | Sell |
17,401
-2,307
| -12% | -$880 | ﹤0.01% | 8689 |
|
|
2018
Q4 | $7K | Buy |
19,708
+301
| +2% | +$383 | ﹤0.01% | 8772 |
|
|
2018
Q3 | $35K | Sell |
19,407
-1,301
| -6% | -$2.16K | ﹤0.01% | 8916 |
|
|
2018
Q2 | $42K | Buy |
20,708
+1,000
| +5% | +$2.08K | ﹤0.01% | 9312 |
|
|
2018
Q1 | $37K | Sell |
19,708
-8,865
| -31% | -$20.1K | ﹤0.01% | 9039 |
|
|
2017
Q4 | $60K | Buy |
28,573
+8,326
| +41% | +$19.5K | ﹤0.01% | 8864 |
|
|
2017
Q3 | $41K | Buy |
20,247
+9,747
| +93% | +$21.4K | ﹤0.01% | 8576 |
|
|
2017
Q2 | $22K | Sell |
10,500
-12,577
| -55% | -$29.1K | ﹤0.01% | 9012 |
|
|
2017
Q1 | $57K | Sell |
23,077
-25,438
| -52% | -$26.1K | ﹤0.01% | 8564 |
|
|
2016
Q4 | $23K | Buy |
+48,515
| New | +$35.9K | ﹤0.01% | 9418 |
|
Other funds holding APOPW
Susquehanna International Group's APOPW Position: Q1 2021 in Review
Susquehanna International Group sold out of Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) in Q1 2021, closing a stake of 28,500 shares — an estimated $5K sold.
Susquehanna International Group first reported a position in APOPW in Q4 2016 and held it in 16 quarters. The position peaked at $60K in Q4 2017. 1 fund tracked by Wall St. Rank holds APOPW as of Q1 2021.
- Susquehanna International Group reported no remaining Cellect Biotechnology Ltd. Warrants to Purchase ADRs position as of Q1 2021 after selling out during the quarter.
- Susquehanna International Group sold 28,500 Cellect Biotechnology Ltd. Warrants to Purchase ADRs shares in Q1 2021, an estimated $5K.
- Susquehanna International Group first reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in Q4 2016 and held it in 16 quarters.
- Susquehanna International Group's Cellect Biotechnology Ltd. Warrants to Purchase ADRs position peaked at $60K in Q4 2017.
- 1 fund tracked by Wall St. Rank held Cellect Biotechnology Ltd. Warrants to Purchase ADRs as of Q1 2021.
Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.